Your session is about to expire
← Back to Search
Doxil + Vinorelbine for Breast Cancer
Study Summary
This trial is testing the safety and efficacy of a two-drug combination (Doxil and vinorelbine) given every 28 days to women with metastatic breast cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Media Library
- I am using or will use effective birth control during and for three months after treatment.I've had over 3 chemotherapy treatments, including early and advanced cancer stages.I have had more than one treatment for my advanced cancer.I have brain metastasis causing symptoms.I have received more than 400 mg/m2 of anthracycline.My cancer got worse or came back within 6 months after my last anthracycline treatment.I have not taken hormone therapy including aromatase inhibitors in the last 2 weeks.I am a woman over 18 with advanced breast cancer confirmed by biopsy.I can care for myself and am up and about more than 50% of my waking hours.I am at least 2 weeks post-surgery and 3 weeks post-radiation, with no lingering side effects.I can attend weekly medical check-ups during my chemotherapy.My cancer can be measured and was checked within the last 2 weeks.I have a history of heart disease and symptoms that limit my physical activity.I have previously been treated with Doxil or vinorelbine.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What potential risks might patients endure with this therapeutic procedure?
"This particular intervention has been assigned a score of 2 on our safety scale, as it is currently in Phase Two trials. This implies that there are clinical data confirming its security but not yet any evidence validating its efficacy."
Is enrollment currently available for this research project?
"Per the information available on clinicaltrials.gov, this medical trial is no longer enrolling patients; the investigation was initially posted in October 2003 and the most recent update occurred on May 30th 2008. However, there are presently 2297 other studies that need volunteers for their trials."
Share this study with friends
Copy Link
Messenger